| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 01/20/2011 | US20110015203 Viral Polymerase Inhibitors |
| 01/20/2011 | US20110015200 Nitrogen-containing bycyclic compounds active on chronic pain conditions |
| 01/20/2011 | US20110015198 Diarylmethylamide derivative having melanin-concentrating hormone receptor antagonism |
| 01/20/2011 | US20110015197 mTOR INHIBITOR SALT FORMS |
| 01/20/2011 | US20110015193 1, 5-dihydro-pyrazolo (3, 4-d) pyrimidin-4-one derivatives and their use as pde9a mudulators for the treatment of cns disorders |
| 01/20/2011 | US20110015190 Gamma secretase modulators |
| 01/20/2011 | US20110015187 Substituted heteroarylamide diazepinopyrimidone derivatives |
| 01/20/2011 | US20110015185 Benzofuran Compounds |
| 01/20/2011 | US20110015178 Amido-Thiophene Compounds and Their Use |
| 01/20/2011 | US20110015175 Bicyclic Compounds for the Reduction of Beta-Amyloid Production |
| 01/20/2011 | US20110015059 Cyclic compound, its metal complex and modified metal complex |
| 01/20/2011 | US20110014154 Aromatic Heterocyclic Fused Indolobenzadiazepine HCV NS5B Inhibitors |
| 01/20/2011 | DE102009034189A1 New (aza)phthalocyanine compounds useful e.g. to prepare a composition for photodynamic chemotherapy of tumors, as a part of an active layer to prepare and operate photovoltaic cells, and as main or addition components in printing ink |
| 01/20/2011 | DE102009033392A1 Heterocyclische Verbindungen als Autotaxin-Inhibitoren II Heterocyclic compounds as inhibitors Autotaxin II |
| 01/20/2011 | CA2778517A1 Substituted triazole and imidazole derivatives as gamma secretase modulators |
| 01/20/2011 | CA2768291A1 3-hydroxypyrrolidine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase |
| 01/20/2011 | CA2768169A1 Aminopyridine derivatives for the treatment of tumors and inflammatory diseases |
| 01/20/2011 | CA2768095A1 Heterocyclic compounds as autotaxin inhibitors ii |
| 01/20/2011 | CA2767764A1 Heterocyclic compound and use thereof |
| 01/20/2011 | CA2767233A1 5-ht3 receptor modulators, methods of making, and use thereof |
| 01/20/2011 | CA2767091A1 Pyrrolopyrazine inhibitors of kinases |
| 01/20/2011 | CA2766883A1 Tricyclic indole-derived spiro derivatives as crth2 modulators |
| 01/20/2011 | CA2765661A1 4-(3-butynyl)aminopyrimidine derivatives as pest control agents for agricultural and horticultural use |
| 01/19/2011 | EP2276085A1 Organic electroluminescent device |
| 01/19/2011 | EP2275425A1 Novel crystalline forms of temozolomide |
| 01/19/2011 | EP2275411A2 Reformatsky Reagent in Stable Form and Process for Producing the Same |
| 01/19/2011 | EP2275108A1 Pharmaceutical preparation comprising dpp-iv inhibitor and other diabetes therapeutic agent in concomitant or combined form |
| 01/19/2011 | EP2274308A1 Pyrrolotriazinone derivatives for use as stearoyl coa desaturase inhibitors |
| 01/19/2011 | EP2274296A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
| 01/19/2011 | EP2274281A1 Hcv protease inhibitors |
| 01/19/2011 | EP2273882A1 Bioactive compounds for treatment of cancer and neurodegenerative diseases |
| 01/19/2011 | EP1922135B1 Hindered cyclic polyamines and their salts for acid gas scrubbing process |
| 01/19/2011 | EP1067123B1 Nitrogenous heterocyclic compounds |
| 01/19/2011 | CN101952296A Pyrrolopyrazine kinase inhibitors |
| 01/19/2011 | CN101952295A Pyrrolopyrazine kinase inhibitors |
| 01/19/2011 | CN101952294A Pyrrolopyrazine kinase inhibitors |
| 01/19/2011 | CN101952293A Pyrazolo [1,5-A] pyrimidine compounds |
| 01/19/2011 | CN101952292A Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 01/19/2011 | CN101952291A 4-(9-(3, 3-difluorocyclopentyl) -5, 7, 7-trimethyl-6-oxo-6, 7, 8, 9-tetrahydro-5h-pyrimido [4, 5-B[1, 4] diazepin-2-ylamino)-3-methoxybenzamide derivatives as inhibitors of the human protein kinases PLK41 to PLK4 for the treatment of proliferative diseases |
| 01/19/2011 | CN101952289A Condensed pentacyclic derivatives for use in the treatment of flaviviridae infections |
| 01/19/2011 | CN101952286A Bicyclic derivatives for use in the treatment of androgen receptor associated conditions |
| 01/19/2011 | CN101952283A Novel imidazo[1,2-a]pyridine and imidazo[1,2-b]pyridazine derivatives |
| 01/19/2011 | CN101948425A Compound as glucocorticoid ligand, pharmaceutical composition including same, kit and method for preparing same |
| 01/19/2011 | CN101560213B Polycyclic compound functioned as inhibitor of enzyme parp, vegfr2 and mlk3 and the application |
| 01/19/2011 | CN101333221B Stabilization method for annular L-proline anhydride configuration |
| 01/19/2011 | CN101307054B Method for preparing symmetrical N,N'-1-4-dialkyl triethylene diammonium tetrafluoroborate |
| 01/19/2011 | CN101296928B Compounds and compositions as protein kinase inhibitors |
| 01/19/2011 | CN101258154B Pyrazolo [3,4-D]azepine derivatives as histamine H3 antagonists |
| 01/19/2011 | CN101239981B Pyrazolo and imidazo-pyrimidine derivatives |
| 01/19/2011 | CN101103031B Pyrrolo pyrimidine derivatives useful for treating proliferative diseases |
| 01/19/2011 | CN101014578B Triazole derivative or salt thereof |
| 01/18/2011 | US7872147 Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole |
| 01/18/2011 | US7872131 vaporizing triethylenediamine (TEDA), gaseous TEDA is passed into a liquid solvent pentane (quenching) to crystallize from the resulting solution and separated off, crystalline TEDA obtained is dissolved in a solvent (dipropylene-1,2-glycol and a stripping gas N2 is passed through the resulting solution |
| 01/18/2011 | US7872125 1-Methyl,3-((1,3-dichloro-phenyl)-carbonylamino-(1-carboxy- eth-1,2-ylene)-(1,4-phenylene)-)quinazolin-2,4-dione; inhibiting the adhesion of VCAM-1 (vascular cellular adhesion molecules-1) to alpha-4 integrin; antiinflammatory agents; cardiovascular disorders; multiple sclerosis; antiarthritic agent |
| 01/18/2011 | US7872010 Substituted diazabicycloalkane derivatives having affinity for nicotinic acetylcholine receptors |
| 01/18/2011 | US7871765 Composition having antitumor effect |
| 01/18/2011 | CA2566160C Pyrrolopyrimidine derivatives useful in cancer treatment |
| 01/18/2011 | CA2500225C Pyrazole compounds |
| 01/18/2011 | CA2432148C Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 01/13/2011 | WO2011006143A2 Compounds and compositions for the treatment of parasitic diseases |
| 01/13/2011 | WO2011006074A1 SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS |
| 01/13/2011 | WO2011005909A2 Process for substituted 3-amino-5-oxo-4,5-dihydro-[1,2,4]triazines |
| 01/13/2011 | WO2011005520A1 Deuterium-modified triazolo-pyridazine derivatives as gaba-a receptor modulators |
| 01/13/2011 | WO2011005295A1 Modulators of the sphingosine-1-phosphate (s1p) receptor useful for the treatment of disorders related thereto |
| 01/13/2011 | WO2011005290A1 Disubstituted oxadiazole derivatives useful in the treatment of autoimmune and inflammatory disorders |
| 01/13/2011 | WO2011005119A1 Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy |
| 01/13/2011 | WO2011003626A1 INDUCTION OF α-HELIX CONFORMATIONS IN PROTEINS AND PEPTIDES |
| 01/13/2011 | WO2011003418A1 Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors |
| 01/13/2011 | WO2010114996A3 Method for preparing cha-type molecular sieves using novel structure directing agents |
| 01/13/2011 | WO2010105141A3 Azaporphyrins and applications thereof |
| 01/13/2011 | WO2010096384A3 Fused benzazepines as neuronal nicotinic acetylcholine receptor ligands |
| 01/13/2011 | US20110009622 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient |
| 01/13/2011 | US20110009619 Polycyclic compound |
| 01/13/2011 | US20110009616 Agent for preventing arteriosclerosis |
| 01/13/2011 | US20110009433 Bicyclic pyrrole compound |
| 01/13/2011 | US20110009429 Heterocyclic compounds as inhibitors of cxcr2 |
| 01/13/2011 | US20110009414 Heterocyclic derivatives and their use as therapeutic agents |
| 01/13/2011 | US20110009406 Tetrahydro-1h-pyrrolo fused pyridones |
| 01/13/2011 | US20110009404 4-aryl-2-anilino-pyrimidines |
| 01/13/2011 | US20110009392 Gamma secretase modulators |
| 01/13/2011 | US20110009389 Imidazole derivative, their production and use |
| 01/13/2011 | US20110009367 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 01/13/2011 | US20110008259 Modulators of cystic fibrosis transmembrane conductance regulator |
| 01/13/2011 | US20110008257 Inhibitors of bruton's tyrosine kinase |
| 01/13/2011 | CA2767664A1 Compounds and compositions for the treatment of parasitic diseases |
| 01/13/2011 | CA2767648A1 Substituted pyrazolo[1,5-a]pyrimidine compounds as trk kinase inhibitors |
| 01/13/2011 | CA2767079A1 Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors |
| 01/13/2011 | CA2767008A1 Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy |
| 01/13/2011 | CA2766343A1 Platelet-activating factor receptor antagonists |
| 01/13/2011 | CA2764173A1 Process for substituted 3-amino-5-oxo-4,5-dihydro-[1,2,4]triazines |
| 01/12/2011 | EP2272849A1 Compound capable of absorbing infrared ray, and microparticles comprising the compound |
| 01/12/2011 | EP2272517A1 Ortho-condensed pyridine and pyrimidine derivatives ( e.g. purines ) as protein kinases inhibitors |
| 01/12/2011 | EP2271648A1 Isoxazoline linked pyrrolo [2,1-c][1,4]benzodiazepine hybrids as potential anticancer agents and the process for preparattion thereof |
| 01/12/2011 | EP2271647A1 C2-fluoro substituted piperazine linked pyrrolo[2,1-c][1,4] benzodiazepine dimers and a process for the preparation thereof |
| 01/12/2011 | EP2271646A1 Apoptosis signal-regulating kinase 1 inhibitors |
| 01/12/2011 | EP2271630A1 Compounds and compositions as protein kinase inhibitors |
| 01/12/2011 | EP2271346A2 Monocyclic cgrp receptor antagonists |
| 01/12/2011 | EP1863819B1 Diazabicyclic aryl derivatives and their use as chinolinergic ligands at the nicotinic acetylcholine receptors |
| 01/12/2011 | EP1682138B1 Heterocyclic inhibitors of mek |
| 01/12/2011 | CN1856313B Therapeutic compounds |